2023 Maine Revised Statutes › TITLE 22: HEALTH AND WELFARE › Subtitle 4: HUMAN SERVICES › Part 3: DRUG ABUSE › Chapter 1604: INTERSTATE PRESCRIPTION MONITORING PROGRAM COMPACT › 22 §7262. Definitions - Article 2

§7262. Definitions - Article 2
As used in this chapter, unless the context otherwise indicates, the following terms have the following meanings.   [PL 2011, c. 217, §1 (NEW).]
1.  Authentication.
"Authentication" means the process of verifying the identity and credentials of a person before authorizing access to prescription data.
[PL 2011, c. 217, §1 (NEW).]
2.  Authorized.
"Authorized" means the granting of access privileges to prescription data.
[PL 2011, c. 217, §1 (NEW).]
3.  Bylaws.
"Bylaws" means those bylaws established by the interstate commission pursuant to section 7268 for its governance or for directing or controlling its actions and conduct.
[PL 2011, c. 217, §1 (NEW).]
4.  Commissioner.
"Commissioner" means the voting representative appointed by each member state pursuant to section 7266.
[PL 2011, c. 217, §1 (NEW).]
5.  Interstate commission or commission.
"Interstate commission" or "commission" means the Interstate Prescription Monitoring Program Commission created pursuant to section 7266.
[PL 2011, c. 217, §1 (NEW).]
6.  Member state.
"Member state" means any state that has adopted a prescription monitoring program and has enacted the enabling compact legislation.
[PL 2011, c. 217, §1 (NEW).]
7.  Practitioner.
"Practitioner" means a person licensed, registered or otherwise permitted to prescribe or dispense a prescription drug.
[PL 2011, c. 217, §1 (NEW).]
8.  Prescription data.
"Prescription data" means data transmitted by a prescription monitoring program that contains patient, prescriber, dispenser and prescription drug information.
[PL 2011, c. 217, §1 (NEW).]
9.  Prescription drug.
"Prescription drug" means any drug required to be reported to a state prescription monitoring program and includes but is not limited to substances listed in the federal Controlled Substances Act.
[PL 2011, c. 217, §1 (NEW).]
10.  Prescription monitoring program.
"Prescription monitoring program" means a program that collects, manages, analyzes and provides prescription data under the auspices of a state.
[PL 2011, c. 217, §1 (NEW).]
11.  Requestor.
"Requestor" means a person authorized by a member state who has initiated a request for prescription data.
[PL 2011, c. 217, §1 (NEW).]
12.  Rule.
"Rule" means a written statement by the interstate commission promulgated pursuant to section 7267 that is of general applicability; implements, interprets or prescribes a policy or provision of the compact; or is an organizational, procedural or practice requirement of the commission and has the force and effect of statutory law in a member state. "Rule" includes the amendment, repeal or suspension of an existing rule.
[PL 2011, c. 217, §1 (NEW).]
13.  State.
"State" means any state, commonwealth, district or territory of the United States.
[PL 2011, c. 217, §1 (NEW).]
14.  Technology infrastructure.
"Technology infrastructure" means the design, deployment and use of both individual technology-based components and the systems of such components to facilitate the transmission of information and prescription data among member states.
[PL 2011, c. 217, §1 (NEW).]
15.  Transmission.
"Transmission" means the release, transfer, provision or disclosure of information or prescription data among member states.
[PL 2011, c. 217, §1 (NEW).]
SECTION HISTORY
PL 2011, c. 217, §1 (NEW).